You are here: Industry Insights > CRISPR

News List

Merck Develops Alternative CRISPR Genome Editing Method americanpharmaceuticalreview
May 18, 2017
Merck has developed a new genome editing tool that makes CRISPR more efficient, flexible and specific, giving researchers more experimental options and faster results that can accelerate drug development and access to new therapies.
Allergan, Editas Medicine partner to develop CRISPR genome-editing medicines for eye diseases firstwordpharma
March 15, 2017
Allergan and Editas Medicine on Tuesday announced that the companies entered into a strategic R&D alliance under which Allergan will receive exclusive access...
Allergan and Editas Medicine Enter to Discover and Develop CRISPR Genome Editing Medicines for Eye D americanpharmaceuticalreview
March 15, 2017
Allergan and Editas Medicine have entered into a strategic research and development alliance under which Allergan will receive exclusive access and the option to license up to five of Editas Medicine's genome-editing ocular programs, including its lead pr
US panel endorses human embryo gene editing, with caveats pharmafile
February 16, 2017
Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy of Sciences (NAS) and the National Academy of Medicine following an international committee in Washington, DC, but only in very specific circumsta

Previous page 1 2 3 4 5 6 7 8 Next page